The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons
- PMID: 29490165
- DOI: 10.1146/annurev-immunol-042617-053420
The Immune Response to Mycobacterium tuberculosis in HIV-1-Coinfected Persons
Abstract
Globally, about 36.7 million people were living with HIV infection at the end of 2015. The most frequent infection co-occurring with HIV-1 is Mycobacterium tuberculosis-374,000 deaths per annum are attributable to HIV-tuberculosis, 75% of those occurring in Africa. HIV-1 infection increases the risk of tuberculosis by a factor of up to 26 and alters its clinical presentation, complicates diagnosis and treatment, and worsens outcome. Although HIV-1-induced depletion of CD4+ T cells underlies all these effects, more widespread immune deficits also contribute to susceptibility and pathogenesis. These defects present a challenge to understand and ameliorate, but also an opportunity to learn and optimize mechanisms that normally protect people against tuberculosis. The most effective means to prevent and ameliorate tuberculosis in HIV-1-infected people is antiretroviral therapy, but this may be complicated by pathological immune deterioration that in turn requires more effective host-directed anti-inflammatory therapies to be derived.
Keywords: HIV-1 infection; drug therapy; immune response; pathogenesis; tuberculosis.
Similar articles
-
Immune variations throughout the course of tuberculosis treatment and its relationship with adrenal hormone changes in HIV-1 patients co-infected with Mycobacterium tuberculosis.Tuberculosis (Edinb). 2021 Mar;127:102045. doi: 10.1016/j.tube.2020.102045. Epub 2021 Jan 2. Tuberculosis (Edinb). 2021. PMID: 33434785 Free PMC article.
-
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome.Semin Immunopathol. 2016 Mar;38(2):185-98. doi: 10.1007/s00281-015-0532-2. Epub 2015 Sep 30. Semin Immunopathol. 2016. PMID: 26423994 Free PMC article. Review.
-
HIV Interferes with Mycobacterium tuberculosis Antigen Presentation in Human Dendritic Cells.Am J Pathol. 2016 Dec;186(12):3083-3093. doi: 10.1016/j.ajpath.2016.08.003. Epub 2016 Oct 13. Am J Pathol. 2016. PMID: 27746182
-
HIV-1 and the Mycobacterium tuberculosis granuloma: A systematic review and meta-analysis.Tuberculosis (Edinb). 2016 May;98:62-76. doi: 10.1016/j.tube.2016.02.010. Epub 2016 Mar 10. Tuberculosis (Edinb). 2016. PMID: 27156620 Review.
-
The effect of antiretroviral treatment on selected genes in whole blood from HIV-infected adults sensitised by Mycobacterium tuberculosis.PLoS One. 2018 Dec 27;13(12):e0209516. doi: 10.1371/journal.pone.0209516. eCollection 2018. PLoS One. 2018. PMID: 30589870 Free PMC article.
Cited by
-
Global prevalence, burden and trend in HIV and drug-susceptible tuberculosis co-infection from 1990 to 2019 and prediction to 2040.Heliyon. 2023 Dec 10;10(1):e23479. doi: 10.1016/j.heliyon.2023.e23479. eCollection 2024 Jan 15. Heliyon. 2023. PMID: 38205310 Free PMC article.
-
CD4+ T cells are homeostatic regulators during Mtb reinfection.bioRxiv [Preprint]. 2023 Dec 21:2023.12.20.572669. doi: 10.1101/2023.12.20.572669. bioRxiv. 2023. PMID: 38187598 Free PMC article. Preprint.
-
Tuberculosis-associated IFN-I induces Siglec-1 on tunneling nanotubes and favors HIV-1 spread in macrophages.Elife. 2020 Mar 30;9:e52535. doi: 10.7554/eLife.52535. Elife. 2020. PMID: 32223897 Free PMC article.
-
The value of transcriptomics in advancing knowledge of the immune response and diagnosis in tuberculosis.Nat Immunol. 2018 Nov;19(11):1159-1168. doi: 10.1038/s41590-018-0225-9. Epub 2018 Oct 17. Nat Immunol. 2018. PMID: 30333612 Free PMC article. Review.
-
Diagnosis and treatment of tuberculosis in adults with HIV.Medicine (Baltimore). 2022 Sep 2;101(35):e30405. doi: 10.1097/MD.0000000000030405. Medicine (Baltimore). 2022. PMID: 36107594 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
